Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia

Pharmacology Biochemistry and Behavior

Volumn 87, Issue 1, 2007, Pages 179-197

  Durukan, Aysan ^a   Tatlisumak, Turgut ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Experimental stroke model; Focal cerebral ischemia; Magnetic resonance imaging; Middle cerebral artery; Mouse; Pathophysiology; Rat; Therapy

Indexed keywords

3 (5 CHLORO 2 METHOXYPHENYL) 3 FLUORO 2,3 DIHYDRO 6 TRIFLUOROMETHYL 1H INDOL 2 ONE; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; [1,2,3,4 TETRAHYDRO 7 (1H IMIDAZOL 1 YL) 6 NITRO 2,3 DIOXO 1 QUINOXALINYL]ACETIC ACID; [[3,4 DIHYDRO 7 MORPHOLINO 2,3 DIOXO 6 (TRIFLUOROMETHYL) 1(2H) QUINOXALINYL]METHYL]PHOSPHONIC ACID; ALTEPLASE; APTIGANEL; CALCIUM ANTAGONIST; CITICOLINE; CLOMETHIAZOLE; DEXTRORPHAN; DIAZEPAM; DISUFENTON SODIUM; EBSELEN; ELIPRODIL; FIBRINOLYTIC AGENT; FLUNARIZINE; FOSPHENYTOIN SODIUM; GAVESTINEL; GLUTAMATE RECEPTOR ANTAGONIST; NALMEFENE; NEUROPROTECTIVE AGENT; NIMODIPINE; NORPHENAZONE; PICLOZOTAN; PROUROKINASE; REPINOTAN; SIPATRIGINE; TISSUE PLASMINOGEN ACTIVATOR; UNINDEXED DRUG;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIFFUSION WEIGHTED IMAGING; DNA MICROARRAY; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DRUG SAFETY; EMBOLECTOMY; EXPERIMENTAL MODEL; FIBRINOLYTIC THERAPY; GENOMICS; GLIA CELL; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LOW DRUG DOSE; META ANALYSIS; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEOMICS; RAT; STROKE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ULTRASOUND; UNSPECIFIED SIDE EFFECT; VASCULAR ENDOTHELIUM;

ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DISEASE MODELS, ANIMAL; HUMANS; MIDDLE CEREBRAL ARTERY;

ANIMALIA; RATTUS; RODENTIA;

EID: 34249852075     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.04.015     Document Type: Article

References (235)

1. Abraham H., Somogyvari-Vigh A., Maderdrut J.L., Vigh S., and Arimura A. Filament size influences temperature changes and brain damage following middle cerebral artery occlusion in rats. Exp Brain Res 142 (2002) 131-138
2. Alexander L.F., Yamamoto Y., Ayoubi S., al-Mefty O., and Smith R.R. Efficacy of tissue plasminogen activator in the lysis of thrombosis of the cerebral venous sinus. Neurosurgery 26 (1990) 559-564
3. Alkayed N.J., Harukuni I., Kimes A.S., London E.D., Traystman R.J., and Hurn P.D. Gender-linked brain injury in experimental stroke. Stroke 29 (1998) 159-165
4. Allen G.V., Cheung R.T., and Cechetto D.F. Neurochemical changes following occlusion of the middle cerebral artery in rats. Neuroscience 68 (1995) 1037-1050
5. Alonso de Lecinana M., Diez-Tejedor E., Gutierrez M., Guerrero S., Carceller F., and Roda J.M. New goals in ischemic stroke therapy: the experimental approach - harmonizing science with practice. Cerebrovasc Dis 20 Suppl 2 (2005) 159-168
6. Aronowski J., Strong R., and Grotta J.C. Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab 17 (1997) 1048-1056
7. Barber P.A., Foniok T., Kirk D., Buchan A.M., Laurent S., Boutry S., et al. MR molecular imaging of early endothelial activation in focal ischemia. Ann Neurol 56 (2004) 116-120
8. Bardutzky J., Shen Q., Henninger N., Bouley J., Duong T.Q., and Fisher M. Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging. Stroke 36 (2005) 2000-2005
9. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., and Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17 (1986) 472-476
10. Belayev L., Alonso O.F., Busto R., Zhao W., and Ginsberg M.D. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 27 (1996) 1616-1622
11. Belayev L., Busto R., Zhao W., and Ginsberg M.D. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res 739 (1996) 88-96
12. Belayev L., Busto R., Zhao W., Fernandez G., and Ginsberg M.D. Middle cerebral artery occlusion in the mouse by intraluminal suture coated with poly-l-lysine: neurological and histological validation. Brain Res 833 (1999) 181-190
13. Brinker G., Franke C., Hoehn M., Uhlenkuken U., and Hossmann K.A. Thrombolysis of cerebral clot embolism in rat: effect of treatment delay. Neuroreport 10 (1999) 3269-3272
14. Brint S., Jacewicz M., Kiessling M., Tanabe J., and Pulsinelli W. Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab 8 (1988) 474-485
15. Buchan A.M., Xue D., and Slivka A. A new model of temporary focal neocortical ischemia in the rat. Stroke 23 (1992) 273-279
16. Busch E., Kruger K., and Hossmann K.A. Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat. Brain Res 778 (1997) 16-24
17. Carano R.A., Li F., Irie K., Helmer K.G., Silva M.D., Fisher M., et al. Multispectral analysis of the temporal evolution of cerebral ischemia in the rat brain. J Magn Reson Imaging 12 (2000) 842-858
18. Carmichael S.T. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2 (2005) 396-409
19. Chen S.T., Hsu C.Y., Hogan E.L., Maricq H., and Balentine J.D. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke 17 (1986) 738-743
20. Chen J., Zacharek A., Zhang C., Jiang H., Li Y., Roberts C., et al. Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J Neurosci 25 (2005) 2366-2375
21. Chen A., Liao W.P., Lu Q., Wong W.S., and Wong P.T. Upregulation of dihydropyrimidinase-related protein 2, spectrin alpha II chain, heat shock cognate protein 70 pseudogene 1 and tropomodulin 2 after focal cerebral ischemia in rats-A proteomics approach. Neurochem Int (2006) [Electronic publication ahead of print]
22. Clark D.L., and Colbourne F. A simple method to induce focal brain hypothermia in rats. J Cereb Blood Flow Metab 27 (2007) 115-122
23. Cooper A. Some experiments and observations on tying the carotid and vertebral arteries, and the pneumo-gastric, phrenic and sympathetic nerves. Guys Hosp Rep 1 (1836) 457-475
24. Coyle P. Different susceptibilities to cerebral infarction in spontaneously hypertensive (SHR) and normotensive Sprague-Dawley rats. Stroke 17 (1986) 520-525
25. D'Hooge R., and De Deyn P.P. Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36 (2001) 60-90
26. Daffertshofer M., Gass A., Ringleb P., Sitzer M., Sliwka U., Els T., et al. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial. Stroke 36 (2005) 1441-1446
27. Danton G.H., and Dietrich W.D. Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 62 (2003) 127-136
28. Davis M., Mendelow A.D., Perry R.H., Chambers I.R., and James O.F. Experimental stroke and neuroprotection in the aging rat brain. Stroke 26 (1995) 1072-1078
29. De Georgia M.A., Krieger D.W., Abou-Chebl A., Devlin T.G., Jauss M., Davis S.M., et al. Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility trial of endovascular cooling. Neurology 63 (2004) 312-317
30. De Keyser J., Sulter G., and Luiten P.G. Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?. Trends Neurosci 22 (1999) 535-540
31. Del Zoppo G.J. Why do all drugs work in animals but none in stroke patients? 1. Drugs promoting cerebral blood flow. J Intern Med 237 (1995) 79-88
32. Del Zoppo G.J. Thrombolysis: from the experimental findings to the clinical practice. Cerebrovasc Dis 17 Suppl 1 (2004) 144-152
33. Del Zoppo G.J., Poeck K., Pessin M.S., Wolpert S.M., Furlan A.J., Ferbert A., et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32 (1992) 78-86
34. Dienel G.A., and Hertz L. Astrocytic contributions to bioenergetics of cerebral ischemia. Glia 50 (2005) 362-388
35. Dietrich W.D., Busto R., Watson B.D., Scheinberg P., and Ginsberg M.D. Photochemically induced cerebral infarction. II. Edema and blood-brain barrier disruption. Acta Neuropathol (Berl) 72 (1987) 326-334
36. Dietrich W.D., Watson B.D., Busto R., Ginsberg M.D., and Bethea J.R. Photochemically induced cerebral infarction. I. Early microvascular alterations. Acta Neuropathol (Berl) 72 (1987) 315-325
37. Dijkhuizen R.M., and Nicolay K. Magnetic resonance imaging in experimental models of brain disorders. J Cereb Blood Flow Metab 23 (2003) 1383-1402
38. Dijkhuizen R.M., Beekwilder J.P., van der Worp H.B., Berkelbach van der Sprenkel J.W., Tulleken K.A., and Nicolay K. Correlation between tissue depolarizations and damage in focal ischemic rat brain. Brain Res 840 (1999) 194-205
39. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22 (1999) 391-397
40. Dittmar M.S., Vatankhah B., Fehm N.P., Schuierer G., Bogdahn U., Horn M., et al. Fischer-344 rats are unsuitable for the MCAO filament model due to their cerebrovascular anatomy. J Neurosci Methods 156 (2006) 50-54
41. Dohmen C., Bosche B., Graf R., Staub F., Kracht L., Sobesky J., et al. Prediction of malignant course in MCA infarction by PET and microdialysis. Stroke 34 (2003) 2152-2158
42. Donnan G.A., Davis S.M., Chambers B.R., Gates P.C., Hankey G.J., McNeil J.J., et al. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) trial study group. JAMA 276 (1996) 961-966
43. Dreier J.P., Woitzik J., Fabricius M., Bhatia R., Major S., Drenckhahn C., et al. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 129 (2006) 3224-3237
44. Duverger D., and MacKenzie E.T. The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age. J Cereb Blood Flow Metab 8 (1988) 449-461
45. Ehrenreich H., Hasselblatt M., Dembowski C., Cepek L., Lewczuk P., Stiefel M., et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8 (2002) 495-505
46. Ehrenreich H., Aust C., Krampe H., Jahn H., Jacob S., Herrmann M., et al. Erythropoietin: novel approaches to neuroprotection in human brain disease. Metab Brain Dis 19 (2004) 195-206
47. Emerich D.F., Dean III R.L., and Bartus R.T. The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct?. Exp Neurol 173 (2002) 168-181
48. Fisher M., and Schaebitz W. An overview of acute stroke therapy: past, present, and future. Arch Intern Med 160 (2000) 3196-3206
49. Fisher M., and Tatlisumak T. Use of animal models has not contributed to development of acute stroke therapies: con. Stroke 36 (2005) 2324-2325
50. Fonteh A.N., Harrington R.J., Huhmer A.F., Biringer R.G., Riggins J.N., and Harrington M.G. Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods. Dis Markers 22 (2006) 39-64
51. Frerichs K.U., Deckert M., Kempski O., Schurer L., Einhaupl K., and Baethmann A. Cerebral sinus and venous thrombosis in rats induces long-term deficits in brain function and morphology-evidence for a cytotoxic genesis. J Cereb Blood Flow Metab 14 (1994) 289-300
52. Fries G., Wallenfang T., Hennen J., Velthaus M., Heimann A., Schild H., et al. Occlusion of the pig superior sagittal sinus, bridging and cortical veins: multistep evolution of sinus-vein thrombosis. J Neurosurg 77 (1992) 127-133
53. Fujimura M., Morita-Fujimura Y., Kawase M., Copin J.C., Calagui B., Epstein C.J., et al. Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome C and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice. J Neurosci 19 (1999) 3414-3422
54. Fukuchi K., Kusuoka H., Watanabe Y., and Nishimura T. Correlation of sequential MR images of microsphere-induced cerebral ischemia with histologic changes in rats. Invest Radiol 34 (1999) 698-703
55. Furlan A., Higashida R., Wechsler L., Gent M., Rowley H., Kase C., et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282 (1999) 2003-2011
56. Furlan A.J., Eyding D., Albers G.W., Al-Rawi Y., Lees K.R., Rowley H.A., et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 37 (2006) 1227-1231
57. Fuxe K., Bjelke B., Andbjer B., Grahn H., Rimondini R., and Agnati L.F. Endothelin-1 induced lesions of the frontoparietal cortex of the rat. A possible model of focal cortical ischemia. Neuroreport 8 (1997) 2623-2629
58. Garcia J.H., Liu K.F., and Ho K.L. Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke 26 (1995) 636-642
59. Gartshore G., Patterson J., and Macrae I.M. Influence of ischemia and reperfusion on the course of brain tissue swelling and blood-brain barrier permeability in a rodent model of transient focal cerebral ischemia. Exp Neurol 147 (1997) 353-360
60. Gerriets T., Stolz E., Walberer M., Kaps M., Bachmann G., and Fisher M. Neuroprotective effects of MK-801 in different rat stroke models for permanent middle cerebral artery occlusion: adverse effects of hypothalamic damage and strategies for its avoidance. Stroke 34 (2003) 2234-2239
61. Gerriets T., Stolz E., Walberer M., Muller C., Kluge A., Bachmann A., et al. Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke 35 (2004) 566-571
62. Gerriets T., Stolz E., Walberer M., Muller C., Rottger C., Kluge A., et al. Complications and pitfalls in rat stroke models for middle cerebral artery occlusion: a comparison between the suture and the macrosphere model using magnetic resonance angiography. Stroke 35 (2004) 2372-2377
63. Gharbawie O.A., and Whishaw I.Q. Parallel stages of learning and recovery of skilled reaching after motor cortex stroke: "oppositions" organize normal and compensatory movements. Behav Brain Res 175 (2006) 249-262
64. Ginsberg M.D. The validity of rodent brain-ischemia models is self-evident. Arch Neurol 53 (1996) 1065-1067
65. Ginsberg M.D., and Busto R. Rodent models of cerebral ischemia. Stroke 20 (1989) 1627-1642
66. Ginsberg M.D., Prado R., Dietrich W.D., Busto R., and Watson B.D. Hyperglycemia reduces the extent of cerebral infarction in rats. Stroke 18 (1987) 570-574
67. Green A.R. Why do neuroprotective drugs that are so promising in animals fail in the clinic? An industry perspective. Clin Exp Pharmacol Physiol 29 (2002) 1030-1034
68. Green R.A., Odergren T., and Ashwood T. Animal models of stroke: do they have value for discovering neuroprotective agents?. Trends Pharmacol Sci 24 (2003) 402-408
69. Grotta J. Why do all drugs work in animals but none in stroke patients? 2. Neuroprotective therapy. J Intern Med 237 (1995) 89-94
70. Grotta J. Stroke treatment in the human versus animal models. In: Ginsberg M.D., and Bogousslavsky J. (Eds). Cerebrovascular disease: pathophysiology, diagnosis, and management (1998), Blackwell Scientific Publications 1901-1906
71. Guglielmo M.A., Chan P.T., Cortez S., Stopa E.G., McMillan P., Johanson C.E., et al. The temporal profile and morphologic features of neuronal death in human stroke resemble those observed in experimental forebrain ischemia: the potential role of apoptosis. Neurol Res 20 (1998) 283-296
72. Gunther A., Kuppers-Tiedt L., Schneider P.M., Kunert I., Berrouschot J., Schneider D., et al. Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia. Eur J Neurosci 21 (2005) 3189-3194
73. Guo J., Liao J.J., Preston J.K., and Batjer H.H. A canine model of acute hindbrain ischemia and reperfusion. Neurosurgery 36 (1995) 986-992
74. Gursoy-Ozdemir Y., Can A., and Dalkara T. Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 35 (2004) 1449-1453
75. Hacke W., Albers G., Al-Rawi Y., Bogousslavsky J., Davalos A., Eliasziw M., et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36 (2005) 66-73
76. Haley Jr. E.C., Lyden P.D., Johnston K.C., and Hemmen T.M. A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke. Stroke 36 (2005) 607-612
77. Hartings J.A., Rolli M.L., Lu X.C., and Tortella F.C. Delayed secondary phase of peri-infarct depolarizations after focal cerebral ischemia: relation to infarct growth and neuroprotection. J Neurosci 23 (2003) 11602-11610
78. Hartings J.A., Williams A.J., and Tortella F.C. Occurrence of nonconvulsive seizures, periodic epileptiform discharges, and intermittent rhythmic delta activity in rat focal ischemia. Exp Neurol 179 (2003) 139-149
79. Hata R., Mies G., Wiessner C., Fritze K., Hesselbarth D., Brinker G., et al. A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging. J Cereb Blood Flow Metab 18 (1998) 367-375
80. He Z., Yamawaki T., Yang S., Day A.L., Simpkins J.W., and Naritomi H. Experimental model of small deep infarcts involving the hypothalamus in rats: changes in body temperature and postural reflex. Stroke 30 (1999) 2743-2751
81. Hennerici M.G., Kay R., Bogousslavsky J., Lenzi G.L., Verstraete M., and Orgogozo J.M. Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: a randomised controlled trial. Lancet 368 (2006) 1871-1878
82. Henninger N., Eberius K.H., Sicard K.M., Kollmar R., Sommer C., Schwab S., et al. A new model of thromboembolic stroke in the posterior circulation of the rat. J Neurosci Methods 156 (2006) 1-9
83. Hilger T., Blunk J.A., Hoehn M., Mies G., and Wester P. Characterization of a novel chronic photothrombotic ring stroke model in rats by magnetic resonance imaging, biochemical imaging, and histology. J Cereb Blood Flow Metab 24 (2004) 789-797
84. Hsu C.Y. Criteria for valid preclinical trials using animal stroke models. Stroke 24 (1993) 633-636
85. Hu X., Wester P., Brannstrom T., Watson B.D., and Gu W. Progressive and reproducible focal cortical ischemia with or without late spontaneous reperfusion generated by a ring-shaped, laser-driven photothrombotic lesion in rats. Brain Res Brain Res Protoc 7 (2001) 76-85
86. Huang Y., and McNamara J.O. Ischemic stroke: "acidotoxicity" is a perpetrator. Cell 118 (2004) 665-666
87. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., and Moskowitz M.A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265 (1994) 1883-1885
88. Huang N.C., Wei J., and Quast M.J. A comparison of the early development of ischemic brain damage in normoglycemic and hyperglycemic rats using magnetic resonance imaging. Exp Brain Res 109 (1996) 33-42
89. Huang Z.G., Xue D., Preston E., Karbalai H., and Buchan A.M. Biphasic opening of the blood-brain barrier following transient focal ischemia: effects of hypothermia. Can J Neurol Sci 26 (1999) 298-304
90. Hudgins W.R., and Garcia J.H. Transorbital approach to the middle cerebral artery of the squirrel monkey: a technique for experimental cerebral infarction applicable to ultrastructural studies. Stroke 1 (1970) 107-111
91. Hunter A.J., Hatcher J., Virley D., Nelson P., Irving E., Hadingham S.J., et al. Functional assessments in mice and rats after focal stroke. Neuropharmacology 39 (2000) 806-816
92. Imai H., Konno K., Nakamura M., Shimizu T., Kubota C., Seki K., et al. A new model of focal cerebral ischemia in the miniature pig. J Neurosurg 104 (2006) 123-132
93. Inui H., Murai T., Yane K., and Matsunaga T. Brainstem ischemic damage following occlusion of the blood vessels in the rat's posterior cerebral circulation. Eur Arch Otorhinolaryngol 253 (1996) 176-181
94. Kameyama M., Suzuki J., Shirane R., and Ogawa A. A new model of bilateral hemispheric ischemia in the rat-three vessel occlusion model. Stroke 16 (1985) 489-493
95. Kaneko D., Nakamura N., and Ogawa T. Cerebral infarction in rats using homologous blood emboli: development of a new experimental model. Stroke 16 (1985) 76-84
96. Kaste M. Use of animal models has not contributed to development of acute stroke therapies: pro. Stroke 36 (2005) 2323-2324
97. Kawamata T., Alexis N.E., Dietrich W.D., and Finklestein S.P. Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat. J Cereb Blood Flow Metab 16 (1996) 542-547
98. Kim J.B., Piao C.S., Lee K.W., Han P.L., Ahn J.I., Lee Y.S., et al. Delayed genomic responses to transient middle cerebral artery occlusion in the rat. J Neurochem 89 (2004) 1271-1282
99. Kimura R., Nakase H., Tamaki R., and Sakaki T. Vascular endothelial growth factor antagonist reduces brain edema formation and venous infarction. Stroke 36 (2005) 1259-1263
100. Kirsch J.R., Traystman R.J., and Hurn P.D. Anesthetics and cerebroprotection: experimental aspects. Int Anesthesiol Clin 34 (1996) 73-93
101. Koizumi J., Yoshida Y., Nakazawa T., and Ooneda G. Experimental studies of ischemic brain edema: 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn Stroke J 8 (1986) 1-8
102. Kong L.Q., Xie J.X., Han H.B., and Liu H.D. Improvements in the intraluminal thread technique to induce focal cerebral ischaemia in rabbits. J Neurosci Methods 137 (2004) 315-319
103. Krieger D.W., and Yenari M.A. Therapeutic hypothermia for acute ischemic stroke: what do laboratory studies teach us?. Stroke 35 (2004) 1482-1489
104. Krieger D.W., De Georgia M.A., Abou-Chebl A., Andrefsky J.C., Sila C.A., Katzan I.L., et al. Cooling for acute ischemic brain damage (cool aid): an open pilot study of induced hypothermia in acute ischemic stroke. Stroke 32 (2001) 1847-1854
105. Kuroiwa T., Ting P., Martinez H., and Klatzo I. The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion. Acta Neuropathol (Berl) 68 (1985) 122-129
106. Kuwabara S., Uno J., and Ishikawa S. A new model of brainstem ischemia in dogs. Stroke 19 (1988) 365-371
107. Laing R.J., Jakubowski J., and Laing R.W. Middle cerebral artery occlusion without craniectomy in rats. Which method works best?. Stroke 24 (1993) 294-297
108. Lauer K.K., Shen H., Stein E.A., Ho K.C., Kampine J.P., and Hudetz A.G. Focal cerebral ischemia in rats produced by intracarotid embolization with viscous silicone. Neurol Res 24 (2002) 181-190
109. Lee D.H., Jo K.D., Kim H.G., Choi S.J., Jung S.M., Ryu D.S., et al. Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study. J Vasc Interv Radiol 13 (2002) 769-774
110. Lees K.R., Zivin J.A., Ashwood T., Davalos A., Davis S.M., Diener H.C., et al. NXY-059 for acute ischemic stroke. N Engl J Med 354 (2006) 588-600
111. Li F., and Fisher M. Animal modeling for developing stroke therapy. In: Fisher M. (Ed). Stroke therapy (2001), Butterworth-Heinemann, Woburn, MA 83-96
112. Li F., Han S., Tatlisumak T., Carano R.A., Irie K., Sotak C.H., et al. A new method to improve in-bore middle cerebral artery occlusion in rats: demonstration with diffusion- and perfusion-weighted imaging. Stroke 29 (1998) 1715-1719
113. Li F., Han S.S., Tatlisumak T., Liu K.F., Garcia J.H., Sotak C.H., et al. Reversal of acute apparent diffusion coefficient abnormalities and delayed neuronal death following transient focal cerebral ischemia in rats. Ann Neurol 46 (1999) 333-342
114. Li F., Omae T., and Fisher M. Spontaneous hyperthermia and its mechanism in the intraluminal suture middle cerebral artery occlusion model of rats. Stroke 30 (1999) 2464-2470
115. Li J., Henman M.C., Doyle K.M., Strbian D., Kirby B.P., Tatlisumak T., et al. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice. Brain Res 1029 (2004) 84-92
116. Li J., Henman M.C., Atkinson J., Fixon-Owoo S., Tatlisumak T., Shaw G.G., et al. The pre-ischaemic neuroprotective effects of the polyamine analogues BU43b and BU36b in permanent and transient focal cerebral ischaemia models in mice. Brain Res 1076 (2006) 209-215
117. Liebetrau M., Gabriejcic-Geiger D., Meyer P., Roether J., and Hamann G.F. Increased calpain expression following experimental cerebral venous thrombosis in rats. Thromb Res 112 (2003) 239-243
118. Lo E.H., Dalkara T., and Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4 (2003) 399-415
119. Lo E.H., Moskowitz M.A., and Jacobs T.P. Exciting, radical, suicidal: how brain cells die after stroke. Stroke 36 (2005) 189-192
120. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
121. Love S. Apoptosis and brain ischaemia. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 267-282
122. Love S., Barber R., and Wilcock G.K. Neuronal death in brain infarcts in man. Neuropathol Appl Neurobiol 26 (2000) 55-66
123. Lu X.C., Williams A.J., Yao C., Berti R., Hartings J.A., Whipple R., et al. Microarray analysis of acute and delayed gene expression profile in rats after focal ischemic brain injury and reperfusion. J Neurosci Res 77 (2004) 843-857
124. Ma J., Zhao L., and Nowak Jr. T.S. Selective, reversible occlusion of the middle cerebral artery in rats by an intraluminal approach. Optimized filament design and methodology. J Neurosci Methods 156 (2006) 76-83
125. MacDonald V.D., Sundt Jr. T.M., and Winkelmann R.K. Histochemical studies in the zone of ischemia following middle cerebral artery occlusion in cats. J Neurosurg 37 (1972) 45-54
126. Mack W.J., Komotar R.J., Mocco J., Coon A.L., Hoh D.J., King R.G., et al. Serial magnetic resonance imaging in experimental primate stroke: validation of MRI for pre-clinical cerebroprotective trials. Neurol Res 25 (2003) 846-852
127. Mackert B.M. The discovery of slowness-recent progress in DC-MEG research. Neurol Clin Neurophysiol 2004 (2004) 41
128. MacManus J.P., and Buchan A.M. Apoptosis after experimental stroke: fact or fashion?. J Neurotrauma 17 (2000) 899-914
129. Macrae I. New models of focal cerebral ischaemia. Br J Clin Pharmacol 34 (1992) 302-308
130. Macrae I.M., Robinson M.J., Graham D.I., Reid J.L., and McCulloch J. Endothelin-1-induced reductions in cerebral blood flow: dose dependency, time course, and neuropathological consequences. J Cereb Blood Flow Metab 13 (1993) 276-284
131. Marsala M., Vanicky I., Tokumine J., Kakinohana O., and Marsala J. Blood-brain barrier changes in global and focal cerebral ischemia. In: Sharma H.S., and Westman J. (Eds). Blood-spinal cord and brain barriers in health and disease (2004), Elsevier, San Diego, California 385-394
132. MAST-1. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial-Italy (MAST-I) Group. Lancet 346 (1995) 1509-1514
133. Matsumoto K., Graf R., Rosner G., Taguchi J., and Heiss W.D. Elevation of neuroactive substances in the cortex of cats during prolonged focal ischemia. J Cereb Blood Flow Metab 13 (1993) 586-594
134. Maulaz A., Piechowski-Jozwiak B., Michel P., and Bogousslavsky J. Selecting patients for early stroke treatment with penumbra images. Cerebrovasc Dis 20 Suppl 2 (2005) 19-24
135. Mayzel-Oreg O., Omae T., Kazemi M., Li F., Fisher M., Cohen Y., et al. Microsphere-induced embolic stroke: an MRI study. Magn Reson Med 51 (2004) 1232-1238
136. McAuley M.A. Rodent models of focal ischemia. Cerebrovasc Brain Metab Rev 7 (1995) 153-180
137. McIlvoy L.H. The effect of hypothermia and hyperthermia on acute brain injury. AACN Clin Issues 16 (2005) 488-500
138. Memezawa H., Minamisawa H., Smith M.L., and Siesjo B.K. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp Brain Res 89 (1992) 67-78
139. Menzies S.A., Hoff J.T., and Betz A.L. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 31 (1992) 100-106
140. Merchenthaler I., Dellovade T.L., and Shughrue P.J. Neuroprotection by estrogen in animal models of global and focal ischemia. Ann N Y Acad Sci 1007 (2003) 89-100
141. Mergenthaler P., Dirnagl U., and Meisel A. Pathophysiology of stroke: lessons from animal models. Metab Brain Dis 19 (2004) 151-167
142. Meyer F.B., Anderson R.E., Sundt Jr. T.M., and Yaksh T.L. Intracellular brain pH, indicator tissue perfusion, electroencephalography, and histology in severe and moderate focal cortical ischemia in the rabbit. J Cereb Blood Flow Metab 6 (1986) 71-78
143. Millan M., and Davalos A. The need for new therapies for acute ischaemic stroke. Cerebrovasc Dis 22 Suppl 1 (2006) 3-9
144. Molnar L., Hegedus K., and Fekete I. A new model for inducing transient cerebral ischemia and subsequent reperfusion in rabbits without craniectomy. Stroke 19 (1988) 1262-1266
145. Murray C.J., and Lopez A.D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349 (1997) 1269-1276
146. Nabika T., Cui Z., and Masuda J. The stroke-prone spontaneously hypertensive rat: how good is it as a model for cerebrovascular diseases?. Cell Mol Neurobiol 24 (2004) 639-646
147. Nakagawa I., Alessandri B., Heimann A., and Kempski O. MitoKATP-channel opener protects against neuronal death in rat venous ischemia. Neurosurgery 57 (2005) 334-340
148. Nakase H., Kakizaki T., Miyamoto K., Hiramatsu K., and Sakaki T. Use of local cerebral blood flow monitoring to predict brain damage after disturbance to the venous circulation: cortical vein occlusion model by photochemical dye. Neurosurgery 37 (1995) 280-285
149. Nedergaard M. Transient focal ischemia in hyperglycemic rats is associated with increased cerebral infarction. Brain Res 408 (1987) 79-85
150. NINDS. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA stroke study group. N Engl J Med 333 (1995) 1581-1587
151. Numano T., Homma K., Iwasaki N., Hyodo K., Nitta N., and Hirose T. In vivo isotropic 3D diffusion tensor mapping of the rat brain using diffusion-weighted 3D MP-RAGE MRI. Magn Reson Imaging 24 (2006) 287-293
152. O'Brien M.D., and Waltz A.G. Transorbital approach for occluding the middle cerebral artery without craniectomy. Stroke 4 (1973) 201-206
153. Oliff H.S., Marek P., Miyazaki B., and Weber E. The neuroprotective efficacy of MK-801 in focal cerebral ischemia varies with rat strain and vendor. Brain Res 731 (1996) 208-212
154. Oliff H.S., Coyle P., and Weber E. Rat strain and vendor differences in collateral anastomoses. J Cereb Blood Flow Metab 17 (1997) 571-576
155. Overgaard K. Thrombolytic therapy in experimental embolic stroke. Cerebrovasc Brain Metab Rev 6 (1994) 257-286
156. Overgaard K., Sereghy T., Boysen G., Pedersen H., Hoyer S., and Diemer N.H. A rat model of reproducible cerebral infarction using thrombotic blood clot emboli. J Cereb Blood Flow Metab 12 (1992) 484-490
157. Pan G., and Wright K.C. Clot embolic stroke in the vertebrobasilar system of rabbits: a transfemoral angiographic technique. Cardiovasc Intervent Radiol 10 (1987) 285-290
158. Papadopoulos S.M., Chandler W.F., Salamat M.S., Topol E.J., and Sackellares J.C. Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke. J Neurosurg 67 (1987) 394-398
159. Pevsner P.H., Eichenbaum J.W., Miller D.C., Pivawer G., Eichenbaum K.D., Stern A., et al. A photothrombotic model of small early ischemic infarcts in the rat brain with histologic and MRI correlation. J Pharmacol Toxicol Methods 45 (2001) 227-233
160. Phan T.G., Wright P.M., Markus R., Howells D.W., Davis S.M., and Donnan G.A. Salvaging the ischaemic penumbra: more than just reperfusion?. Clin Exp Pharmacol Physiol 29 (2002) 1-10
161. Plaschke K., Martin E., Bardenheuer H.J., Knauth M., and Sartor K. Transfemoral digital subtraction angiography for assessment of vertebral artery occlusion in rats. Stroke 31 (2000) 1789-1790
162. Prado R., Ginsberg M.D., Dietrich W.D., Watson B.D., and Busto R. Hyperglycemia increases infarct size in collaterally perfused but not end-arterial vascular territories. J Cereb Blood Flow Metab 8 (1988) 186-192
163. Pulsinelli W., and Jacewicz M. Animal models of brain ischemia. In: Barnett H.J., Mohr J.P., Stein B.M., and Yatsu F.M. (Eds). Stroke: pathophysiology, diagnosis, and management (1992), Churchill Livingstone, New York, NY, USA 49-67
164. Purdy P.D., Devous Sr. M.D., Batjer H.H., White III C.L., Meyer Y., and Samson D.S. Microfibrillar collagen model of canine cerebral infarction. Stroke 20 (1989) 1361-1367
165. Quinn L.P., Grundy R.I., Campbell C.A., Collier S., Lawman A., Stean T.O., et al. A novel behavioural registration system LABORAS and the social interaction paradigm detect long-term functional deficits following middle cerebral artery occlusion in the rat. Brain Res 1031 (2005) 118-124
166. Rapp J.H., Pan X.M., Yu B., Swanson R.A., Higashida R.T., Simpson P., et al. Cerebral ischemia and infarction from atheroemboli < 100 micron in size. Stroke 34 (2003) 1976-1980
167. Reese T., Bochelen D., Baumann D., Rausch M., Sauter A., and Rudin M. Impaired functionality of reperfused brain tissue following short transient focal ischemia in rats. Magn Reson Imaging 20 (2002) 447-454
168. Rivers C.S., and Wardlaw J.M. What has diffusion imaging in animals told us about diffusion imaging in patients with ischaemic stroke?. Cerebrovasc Dis 19 (2005) 328-336
169. Robinson M.J., Macrae I.M., Todd M., Reid J.L., and McCulloch J. Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat. Neurosci Lett 118 (1990) 269-272
170. Robinson R.G., Shoemaker W.J., Schlumpf M., Valk T., and Bloom F.E. Effect of experimental cerebral infarction in rat brain on catecholamines and behaviour. Nature 255 (1975) 332-334
171. Roof R.L., Schielke G.P., Ren X., and Hall E.D. A comparison of long-term functional outcome after 2 middle cerebral artery occlusion models in rats. Stroke 32 (2001) 2648-2657
172. Roos M.W., Ericsson A., Berg M., Sperber G.O., Sjoquist M., and Meyerson B.J. Functional evaluation of cerebral microembolization in the rat. Brain Res 961 (2003) 15-21
173. Rother J., Waggie K., van Bruggen N., de Crespigny A.J., and Moseley M.E. Experimental cerebral venous thrombosis: evaluation using magnetic resonance imaging. J Cereb Blood Flow Metab 16 (1996) 1353-1361
174. Sacco R.L., Chong J.Y., Prabhakaran S., and Elkind M.S. Experimental treatments for acute ischaemic stroke. Lancet 369 (2007) 331-341
175. Sadamoto Y., Igase K., Sakanaka M., Sato K., Otsuka H., Sakaki S., et al. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun 253 (1998) 26-32
176. Sairanen T., Karjalainen-Lindsberg M.L., Paetau A., Ijas P., and Lindsberg P.J. Apoptosis dominant in the periinfarct area of human ischaemic stroke-a possible target of antiapoptotic treatments. Brain 129 (2006) 189-199
177. Sarwar M., Virapongse C., and Carbo P. Experimental production of superior sagittal sinus thrombosis in the dog. AJNR Am J Neuroradiol 6 (1985) 19-22
178. Schaller B., and Graf R. Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy. J Cereb Blood Flow Metab 24 (2004) 351-371
179. Schaller B., Graf R., Wienhard K., and Heiss W.D. A new animal model of cerebral venous infarction: ligation of the posterior part of the superior sagittal sinus in the cat. Swiss Med Wkly 133 (2003) 412-418
180. Schellinger P.D., Kaste M., and Hacke W. An update on thrombolytic therapy for acute stroke. Curr Opin Neurol 17 (2004) 69-77
181. Schilling M., Besselmann M., Leonhard C., Mueller M., Ringelstein E.B., and Kiefer R. Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol 183 (2003) 25-33
182. Schmid-Elsaesser R., Zausinger S., Hungerhuber E., Baethmann A., and Reulen H.J. A critical reevaluation of the intraluminal thread model of focal cerebral ischemia: evidence of inadvertent premature reperfusion and subarachnoid hemorrhage in rats by laser-Doppler flowmetry. Stroke 29 (1998) 2162-2170
183. Schmidt-Kastner R., Zhang B., Belayev L., Khoutorova L., Amin R., Busto R., et al. DNA microarray analysis of cortical gene expression during early recirculation after focal brain ischemia in rat. Brain Res Mol Brain Res 108 (2002) 81-93
184. Schuhmann M.U., Heine G., Skardelly M., Jaeger M., and Selle H. Brain injury and proteomics/peptidomics: is it relevant? An overview. Acta Neurochir Suppl 95 (2005) 465-470
185. Schumacher M. Microangiographic study of the normal anatomy of the cerebral venous system in rats. Neuroradiology 26 (1984) 137-140
186. Schumacher H.C., Gupta R., Higashida R.T., and Meyers P.M. Advances in revascularization for acute ischemic stroke treatment. Expert Rev Neurother 5 (2005) 189-201
187. Seshadri S., Beiser A., Kelly-Hayes M., Kase C.S., Au R., Kannel W.B., et al. The lifetime risk of stroke: estimates from the Framingham study. Stroke 37 (2006) 345-350
188. Shapira S., Sapir M., Wengier A., Grauer E., and Kadar T. Aging has a complex effect on a rat model of ischemic stroke. Brain Res 925 (2002) 148-158
189. Sharkey J., Ritchie I.M., and Kelly P.A. Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 13 (1993) 865-871
190. Sherman D.G., Atkinson R.P., Chippendale T., Levin K.A., Ng K., Futrell N., et al. Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke treatment with Ancrod trial. JAMA 283 (2000) 2395-2403
191. Shigeno T., Teasdale G.M., McCulloch J., and Graham D.I. Recirculation model following MCA occlusion in rats. Cerebral blood flow, cerebrovascular permeability, and brain edema. J Neurosurg 63 (1985) 272-277
192. Shimamura N., Matchett G., Tsubokawa T., Ohkuma H., and Zhang J. Comparison of silicon-coated nylon suture to plain nylon suture in the rat middle cerebral artery occlusion model. J Neurosci Methods 156 (2006) 161-165
193. Shuaib A. Neuroprotection - STAIR-way to the future?. Cerebrovasc Dis 22 Suppl 1 (2006) 10-17
194. Siesjo B.K., Katsura K., and Kristian T. Acidosis-related damage. Adv Neurol 71 (1996) 209-233
195. Smith W.S. Pathophysiology of focal cerebral ischemia: a therapeutic perspective. J Vasc Interv Radiol 15 (2004) S3-S12
196. Smith W.S., Sung G., Starkman S., Saver J.L., Kidwell C.S., Gobin Y.P., et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36 (2005) 1432-1438
197. STAIR. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30 (1999) 2752-2758
198. Sugawara T., Fujimura M., Noshita N., Kim G.W., Saito A., Hayashi T., et al. Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx 1 (2004) 17-25
199. Sugimori H., Yao H., Ooboshi H., Ibayashi S., and Iida M. Krypton laser-induced photothrombotic distal middle cerebral artery occlusion without craniectomy in mice. Brain Res Brain Res Protoc 13 (2004) 189-196
200. Suzuki J., Yoshimoto T., Tnanka S., and Sakamoto T. Production of various models of cerebral infarction in the dog by means of occlusion of intracranial trunk arteries. Stroke 11 (1980) 337-341
201. Takano K., Latour L.L., Formato J.E., Carano R.A., Helmer K.G., Hasegawa Y., et al. The role of spreading depression in focal ischemia evaluated by diffusion mapping. Ann Neurol 39 (1996) 308-318
202. Takano K., Carano R.A., Tatlisumak T., Meiler M., Sotak C.H., Kleinert H.D., et al. Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging. Neurology 50 (1998) 870-875
203. Takano K., Tatlisumak T., Bergmann A.G., Gibson III D.G., and Fisher M. Reproducibility and reliability of middle cerebral artery occlusion using a silicone-coated suture (Koizumi) in rats. J Neurol Sci 153 (1997) 8-11
204. Takano K., Tatlisumak T., Formato J.E., Carano R.A., Bergmann A.G., Pullan L.M., et al. Glycine site antagonist attenuates infarct size in experimental focal ischemia. Postmortem and diffusion mapping studies. Stroke 28 (1997) 1255-1262
205. Takizawa S., Hogan M., and Hakim A.M. The effects of a competitive NMDA receptor antagonist (CGS-19755) on cerebral blood flow and pH in focal ischemia. J Cereb Blood Flow Metab 11 (1991) 786-793
206. Tamura A., Graham D.I., McCulloch J., and Teasdale G.M. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1 (1981) 53-60
207. Taniguchi T., Morikawa E., Mori T., and Matsui T. Neuroprotective efficacy of selective brain hypothermia induced by a novel external cooling device on permanent cerebral ischemia in rats. Neurol Res 27 (2005) 613-619
208. Tatlisumak T., and Li F. Use of diffusion- and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke. Curr Drug Targets CNS Neurol Disord 2 (2003) 131-141
209. Tatlisumak T., Carano R.A., Takano K., Opgenorth T.J., Sotak C.H., and Fisher M. A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: a diffusion and perfusion MRI study. Stroke 29 (1998) 850-857
210. Tatlisumak T., Takano K., Carano R.A., Miller L.P., Foster A.C., and Fisher M. Delayed treatment with an adenosine kinase inhibitor, GP683, attenuates infarct size in rats with temporary middle cerebral artery occlusion. Stroke 29 (1998) 1952-1958
211. Tatlisumak T., Takano K., Meiler M.R., and Fisher M. A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion. Stroke 29 (1998) 190-195
212. Tatlisumak T., Strbian D., Abo Ramadan U., and Li F. The role of diffusion- and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke: from laboratory to clinics. Curr Vasc Pharmacol 2 (2004) 343-355
213. Toombs C.F. New directions in thrombolytic therapy. Curr Opin Pharmacol 1 (2001) 164-168
214. Trendelenburg G., and Dirnagl U. Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 50 (2005) 307-320
215. Tureyen K., Vemuganti R., Sailor K.A., and Dempsey R.J. Ideal suture diameter is critical for consistent middle cerebral artery occlusion in mice. Neurosurgery 56 (2005) 196-200
216. Unal-Cevik I., Kilinc M., Can A., Gursoy-Ozdemir Y., and Dalkara T. Apoptotic and necrotic death mechanisms are concomitantly activated in the same cell after cerebral ischemia. Stroke 35 (2004) 2189-2194
217. Vosko M.R., Rother J., Friedl B., Bultemeier G., Kloss C.U., and Hamann G.F. Microvascular damage following experimental sinus-vein thrombosis in rats. Acta Neuropathol (Berl) 106 (2003) 501-505
218. Wang R.Y., Wang P.S., and Yang Y.R. Effect of age in rats following middle cerebral artery occlusion. Gerontology 49 (2003) 27-32
219. Warlow C.P. Epidemiology of stroke. Lancet 352 Suppl 3 (1998) SIII1-SIII4
220. Watanabe O., Bremer A.M., and West C.R. Experimental regional cerebral ischemia in the middle cerebral artery territory in primates. Part 1: angio-anatomy and description of an experimental model with selective embolization of the internal carotid artery bifurcation. Stroke 8 (1977) 61-70
221. Watson B.D., Dietrich W.D., Busto R., Wachtel M.S., and Ginsberg M.D. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann Neurol 17 (1985) 497-504
222. Wester P., Watson B.D., Prado R., and Dietrich W.D. A photothrombotic 'ring' model of rat stroke-in-evolution displaying putative penumbral inversion. Stroke 26 (1995) 444-450
223. Wiebers D.O., Adams Jr. H.P., and Whisnant J.P. Animal models of stroke: are they relevant to human disease?. Stroke 21 (1990) 1-3
224. Woitzik J., and Schilling L. Control of completeness and immediate detection of bleeding by a single laser-Doppler flow probe during intravascular middle cerebral artery occlusion in rats. J Neurosci Methods 122 (2002) 75-78
225. Woitzik J., Schneider U.C., Thome C., Schroeck H., and Schilling L. Comparison of different intravascular thread occlusion models for experimental stroke in rats. J Neurosci Methods 151 (2006) 224-231
226. Wojak J.C., DeCrescito V., and Young W. Basilar artery occlusion in rats. Stroke 22 (1991) 247-252
227. Yamaguchi T., Suzuki M., and Yamamoto M. YM796, a novel muscarinic agonist, improves the impairment of learning behavior in a rat model of chronic focal cerebral ischemia. Brain Res 669 (1995) 107-114
228. Yang G.Y., Gong C., Qin Z., Liu X.H., and Lorris Betz A. Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice. Brain Res Mol Brain Res 69 (1999) 135-143
229. Yang Y., Yang T., Li Q., Wang C.X., and Shuaib A. A new reproducible focal cerebral ischemia model by introduction of polyvinylsiloxane into the middle cerebral artery: a comparison study. J Neurosci Methods 118 (2002) 199-206
230. Zarow G.J., Karibe H., States B.A., Graham S.H., and Weinstein P.R. Endovascular suture occlusion of the middle cerebral artery in rats: effect of suture insertion distance on cerebral blood flow, infarct distribution and infarct volume. Neurol Res 19 (1997) 409-416
231. Zausinger S., Baethmann A., and Schmid-Elsaesser R. Anesthetic methods in rats determine outcome after experimental focal cerebral ischemia: mechanical ventilation is required to obtain controlled experimental conditions. Brain Res Brain Res Protoc 9 (2002) 112-121
232. Zhang L., Zhang Z.G., Zhang C., Zhang R.L., and Chopp M. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model. Stroke 35 (2004) 2890-2895
233. Zhang L., Zhang R.L., Wang Y., Zhang C., Zhang Z.G., Meng H., et al. Functional recovery in aged and young rats after embolic stroke: treatment with a phosphodiesterase type 5 inhibitor. Stroke 36 (2005) 847-852
234. Zhao W., Belayev L., and Ginsberg M.D. Transient middle cerebral artery occlusion by intraluminal suture: II. Neurological deficits, and pixel-based correlation of histopathology with local blood flow and glucose utilization. J Cereb Blood Flow Metab 17 (1997) 1281-1290
235. Zivin J.A., DeGirolami U., Kochhar A., Lyden P.D., Mazzarella V., Hemenway C.C., et al. A model for quantitative evaluation of embolic stroke therapy. Brain Res 435 (1987) 305-309